Excellent Local Control From Radiation Therapy for High-Risk Neuroblastoma

International Journal of Radiation Oncology Biology Physics

Volumn 74, Issue 5, 2009, Pages 1549-1554

  Gatcombe, Heather G ^a   Marcus Jr , R B ^b   Katzenstein, Howard M ^a   Tighiouart, Mourad ^a   Esiashvili, Natia ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

High risk; Local control; Neuroblastoma; Radiation

Indexed keywords

CANCER MANAGEMENT; CLINICAL TRIAL; HIGH RISK; INDUCTION CHEMOTHERAPY; LOCAL CONTROL; LOCAL RECURRENCE; MULTIMODALITY THERAPY; NEUROBLASTOMA; OVERALL SURVIVAL; RADIATION DOSE; RADIATION THERAPY; RESIDUAL DISEASE; TUMOR SITE;

CHEMOTHERAPY; RADIATION; RADIOTHERAPY; SURGERY;

DISEASE CONTROL;

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; TOPOTECAN; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BRAIN SURGERY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER REGRESSION; CANCER RELAPSE; CANCER RISK; CANCER SURGERY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; INFANT; INTENSITY MODULATED RADIATION THERAPY; MALE; NEUROBLASTOMA; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; WHOLE BODY RADIATION;

ABDOMINAL NEOPLASMS; ADOLESCENT; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; GENE AMPLIFICATION; GENES, MYC; HUMANS; INFANT; MALE; NEUROBLASTOMA; PELVIC NEOPLASMS; RADIOTHERAPY DOSAGE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RISK; THORACIC NEOPLASMS; YOUNG ADULT;

EID: 67651101086     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.10.069     Document Type: Article

References (25)

1. De Bernardi B., Nicolas B., Boni L., et al. Disseminated neuroblastoma in children older than one year at diagnosis: Comparable results with three consecutive high-dose protocols adopted by the Italian Co-Operative Group for Neuroblastoma. J Clin Oncol 21 (2003) 1592-1601
2. Matthay K.K., Villablanca J.G., Seeger R.C., et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 341 (1999) 1165-1173
3. Matthay K.K. Impact of myeloablative therapy with bone marrow transplantation in advanced neuroblastoma. Bone Marrow Transplant 18 Suppl. 3 (1996) S21-S24
4. Kushner B.H., LaQuaglia M.P., Bonilla M.A., et al. Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age. J Clin Oncol 12 (1994) 2607-2613
5. Cheung N.K., Kushner B.H., Cheung I.Y., et al. Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age. J Clin Oncol 16 (1998) 3053-3060
6. Stram D.O., Matthay K.K., O'Leary M., et al. Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies. J Clin Oncol 14 (1996) 2417-2426
7. Haas-Kogan D.A., Swift P.S., Selch M., et al. Impact of radiotherapy for high-risk neuroblastoma: A Children's Cancer Group study. Int J Radiat Oncol Biol Phys 56 (2003) 28-39
8. Kushner B.H., Wolden S., LaQuaglia M.P., et al. Hyperfractionated low-dose radiotherapy for high-risk neuroblastoma after intensive chemotherapy and surgery. J Clin Oncol 19 (2001) 2821-2828
9. Marcus K.J., Shamberger R., Litman H., et al. Primary tumor control in patients with Stage 3/4 unfavorable neuroblastoma treated with tandem double autologous stem cell transplants. J Pediatr Hematol Oncol 25 (2003) 934-940
10. Brodeur G.M., Kletzel M., Cohn S.L., et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11 (1993) 1466-1477
11. Haas-Kogan D.A., Fisch B.M., Wara W.M., et al. Intraoperative radiation therapy for high-risk pediatric neuroblastoma. Int J Radiat Oncol Biol Phys 47 (2000) 985-992
12. Browne M., Kletzel M., Cohn S.L., et al. Excellent local tumor control regardless of extent of surgical resection after treatment on the Chicago Pilot II protocol for neuroblastoma. J Pediatr Surg 41 (2006) 271-276
13. Zachariou Z., Sieverts H., Eble M.J., et al. IORT (intraoperative radiotherapy) in neuroblastoma: Experience and first results. Eur J Pediatr Surg 12 (2002) 251-254
14. Bradfield S.M., Douglas J.G., Hawkins D.S., et al. Fractionated low-dose radiotherapy after myeloablative stem cell transplantation for local control in patients with high-risk neuroblastoma. Cancer 100 (2004) 1268-1275
15. Paulino A.C., Ferenci M.S., Chiang K.Y., et al. Comparison of conventional to intensity modulated radiation therapy for abdominal neuroblastoma. Pediatr Blood Cancer 46 (2006) 739-744
16. Adkins E.S., Sawin R., Gerbing R.B., et al. Efficacy of complete resection for high-risk neuroblastoma: A Children's Cancer Group study. J Pediatr Surg 39 (2004) 931-936
17. La Quaglia M.P., et al. The impact of gross total resection on local control and survival in high-risk neuroblastoma. J Pediatr Surg 39 (2004) 412-417 discussion 412-417
18. Matthay K.K., Perez C., Seeger R.C., et al. Successful treatment of Stage III neuroblastoma based on prospective biologic staging: A Children's Cancer Group study. J Clin Oncol 16 (1998) 1256-1264
19. Gillis A.M., Sutton E., Dewitt K.D., et al. Long-term outcome and toxicities of intraoperative radiotherapy for high-risk neuroblastoma. Int J Radiat Oncol Biol Phys 69 (2007) 858-864
20. Children's Oncology Group. Available at: http://www.childrensoncologygroup.org. Accessed June 2008.
21. von Allmen D., Grupp S., Diller L., et al. Aggressive surgical therapy and radiotherapy for patients with high-risk neuroblastoma treated with rapid sequence tandem transplant. J Pediatr Surg 40 (2005) 936-941 discussion 941
22. von Schweinitz D., Hero B., and Berthold F. The impact of surgical radicality on outcome in childhood neuroblastoma. Eur J Pediatr Surg 12 (2002) 402-409
23. Philip T., Ladenstein R., Zucker J.M., et al. Double megatherapy and autologous bone marrow transplantation for advanced neuroblastoma: The LMCE2 study. Br J Cancer 67 (1993) 119-127
24. Grupp S.A., Stern J.W., Bunin N., et al. Tandem high-dose therapy in rapid sequence for children with high-risk neuroblastoma. J Clin Oncol 18 (2000) 2567-2575
25. Kletzel M., Katzenstein H.M., Haut P.R., et al. Treatment of high-risk neuroblastoma with triple-tandem high-dose therapy and stem-cell rescue: Results of the Chicago Pilot II Study. J Clin Oncol 20 (2002) 2284-2292